Organisation
Basic (bio-) Medical Sciences
Department
Basic and applied biomedical research, and biomedical science-based higher education.
Current researchers
81 - 90 of 155 results
- Hediel Madhloum (Member)
- Samuel Madureira Silva (Member)
- Ken Maes (Member)
- Debanjana Majumdar (Member)
- Myrthe Mampay (Member)
- Inge Mannaerts (Member)
- Marta Marco Aragon (Member)
- Ken Matsumoto (Member)
- Fien Meeus (Member)
- Eline Menu (Member)
Projects
81 - 90 of 141
- Targeting the hypoxia-induced metabolic changes in multiple myeloma to conquer drug resistance.From1 Oct 2019 → 31 Jan 2024Funding: FWO fellowships
- DohART-net: Periconceptional Programming of Health Training NetworkFrom1 Jul 2019 → 30 Sep 2023Funding: H2020-EU.1.3.- EXCELLEN SCIENCE - Marie Skłodowska-Curie actions
- SRP-Groeifinanciering: Molecular Portrait of Pancreatic Tumours: Veni, vidi, viciFrom1 Mar 2019 → TodayFunding: BOF - projects
- Development of a NanoCAR-T cell approach for the treatment of multiple myelomaFrom1 Jan 2019 → 31 Dec 2023Funding: FWO fellowships
- Acinar cell specific susceptibility for tumor development in the pancreas: target the critical regulators for therapyFrom1 Jan 2019 → 31 Dec 2022Funding: FWO research project (including WEAVE projects)
- RNAct: Enabling proteins with RNA recognition motifs for synthetic biology and bio-analytics.From1 Jan 2019 → 31 Dec 2022Funding: H2020-EU.1.3.- EXCELLEN SCIENCE - Marie Skłodowska-Curie actions
- CardioReGenix: Development of Next-Generation Gene Therapies for Cardiovascular DiseaseFrom1 Jan 2019 → TodayFunding: H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and wellbeing
- Enhancing the immunogenicity and antitumor efficacy of virotherapy by supplementing an oncolytic virus with checkpoint inhibition and immunological cell death inducersFrom1 Jan 2019 → 31 Dec 2022Funding: FWO fellowships
- RNAct: Enabling proteins with RNA recognition motifs for synthetic biology and bio-analytics (OZR Bonus EU)From1 Jan 2019 → 31 Dec 2022Funding: University - Project driven research
- Smart design nanoParticles to Activate immune Responses against Cancer (SPARC)From1 Jan 2019 → 31 Dec 2022Funding: FWO research project (including WEAVE projects)
Publications
1 - 10 of 1112
- PET/CT studies of multiple myeloma using (18) F-FDG and (18) F-NaF
Authors: Christos Sachpekidis, Hartmut Goldschmidt, Dirk Hose, Leyun Pan, Caixia Cheng, Klaus Kopka, Uwe Haberkorn, Antonia Dimitrakopoulou-Strauss
Pages: 1343-1353 - Tumor cells in multiple myeloma patients inhibit myeloma-reactive T cells through carcinoembryonic antigen-related cell adhesion molecule-6
Authors: Mathias Witzens-Harig, Dirk Hose, Simone Jünger, Christina Pfirschke, Nisit Khandelwal, Ludmila Umansky, Anja Seckinger, Heinke Conrad, Bettina Brackertz, Thierry Rème, et al.
Pages: 4493-4503 - Addition of cyclophosphamide on insufficient response to pomalidomide and dexamethasone
Authors: Katja C Weisel, Christof Scheid, Manola Zago, Britta Besemer, Elias K Mai, Mathias Haenel, Jan Duerig, Markus Munder, Hans-Walter Lindemann, Anja Seckinger, et al.
- DNA repair pathways in human multiple myeloma
Authors: Claire Gourzones-Dmitriev, Alboukadel Kassambara, Surinder S Sahota, Thierry Rème, Jérôme Moreaux, Pascal Bourquard, Dirk Hose, Philippe Pasero, Angelos Constantinou, Bernard Klein
Pages: 2760-2773 - Daratumumab for systemic AL amyloidosis
Authors: Christoph R Kimmich, Tobias Terzer, Axel Benner, Tobias Dittrich, Kaya Veelken, Alexander Carpinteiro, Timon Hansen, Hartmut Goldschmidt, Anja Seckinger, Dirk Hose, et al.
Pages: 1517-1530 - Thalidomide maintenance therapy maturates the T cell compartment and compromises antigen-specific antitumor immunity in patients with multiple myeloma
Authors: Isabelle Herth, Mathias Witzens-Harig, Philipp Beckhove, Dirk Hose, Tobias Meissner, Brigitte Neuber, Melanie Engelhardt, Jürgen Haas, Kai Neben, Anthony D Ho, et al.
Pages: 231-240 - The histone deacetylase SIRT2 stabilizes Myc oncoproteins
Authors: P Y Liu, N Xu, A Malyukova, Christopher J Scarlett, Y T Sun, X D Zhang, D Ling, S-P Su, Claudia Benitez-Nelson, David K Chang, et al.
Pages: 503-514 - Concomitant gain of 1q21 and MYC translocation define a poor prognostic subgroup of hyperdiploid multiple myeloma
Authors: Niels Weinhold, Desiree Kirn, Anja Seckinger, Thomas Hielscher, Martin Granzow, Uta Bertsch, Gerlinde Egerer, Hans J Salwender, Igor W Blau, Katja Weisel, et al.
Pages: e116-e119 - Hitting the target without pulling the trigger.
Authors: Thierry VandenDriessche, Marinee K Chuah
Pages: 4-6 - Combinatorial strategies for the induction of immunogenic cell death.
Authors: L Bezu, LC Gomes-de-Silva, Heleen Dewitte, Karine Breckpot, J Fucikova, Radek Spisek, Lorenzo Galluzzi, Oliver Kepp, Guido Kroemer